On the International Agency for Research on Cancer classification of glyphosate as a probable human carcinogen

被引:41
|
作者
Tarone, Robert E. [1 ,2 ]
机构
[1] US Natl Canc Inst, Rockville, MD USA
[2] Int Epidemiol Inst, Rockville, MD USA
关键词
carcinogen classification; glyphosate; International Agency for Research on Cancer; PRINCIPLES UNDERLYING SCIENCE; PESTICIDE USE; AGRICULTURAL HEALTH; EPIDEMIOLOGIC ENTERPRISE; PROSTATE-CANCER; RISK; PLEA; IARC; APPLICATORS; ADHERENCE;
D O I
10.1097/CEJ.0000000000000289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The recent classification by International Agency for Research on Cancer (IARC) of the herbicide glyphosate as a probable human carcinogen has generated considerable discussion. The classification is at variance with evaluations of the carcinogenic potential of glyphosate by several national and international regulatory bodies. The basis for the IARC classification is examined under the assumptions that the IARC criteria are reasonable and that the body of scientific studies determined by IARC staff to be relevant to the evaluation of glyphosate by the Monograph Working Group is sufficiently complete. It is shown that the classification of glyphosate as a probable human carcinogen was the result of a flawed and incomplete summary of the experimental evidence evaluated by the Working Group. Rational and effective cancer prevention activities depend on scientifically sound and unbiased assessments of the carcinogenic potential of suspected agents. Implications of the erroneous classification of glyphosate with respect to the IARC Monograph Working Group deliberative process are discussed.
引用
收藏
页码:82 / 87
页数:6
相关论文
共 50 条
  • [1] Glyphosate Herbicide as Endocrine Disruptor and Probable Human Carcinogen: Current Knowledge and Future Direction
    Lorenz, Virginia
    Rossetti, Maria Florencia
    Dallegrave, Eliane
    Milesi, Maria Mercedes
    Varayoud, Jorgelina
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [2] To be or not to be a carcinogen; delving into the glyphosate classification controversy
    Roma Paumgartten, Francisco Jose
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 55
  • [3] INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
    HIGGINSO.J
    WHO CHRONICLE, 1968, 22 (12) : 517 - &
  • [4] INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
    SOMERS, E
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1985, 133 (09) : 845 - 846
  • [5] INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
    HIGGINSON, J
    ARCHIVES OF PATHOLOGY, 1974, 98 (05): : 289 - 291
  • [6] Human papillomavirus and oral cancer:: The international agency for research on cancer multicenter study
    Herrero, R
    Castellsagué, X
    Pawlita, M
    Lissowska, J
    Kee, F
    Balaram, P
    Rajkumar, T
    Sridhar, H
    Rose, B
    Pintos, J
    Fernández, L
    Idris, A
    Sánchez, MJ
    Nieto, A
    Talamini, R
    Tavani, A
    Bosch, FX
    Reidel, U
    Snijders, PJF
    Meijer, CJLM
    Viscidi, R
    Munoz, N
    Franceschi, S
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (23): : 1772 - 1783
  • [7] International Agency for Research on Cancer at a crossroads
    Saracci, Rodolfo
    LANCET, 2008, 372 (9635): : 291 - 292
  • [8] Tomatis and the international agency for research on cancer
    Berrino, Franco
    EPIDEMIOLOGIA & PREVENZIONE, 2007, 31 (05): : 236 - 237
  • [9] Misconceptions and misuse of international agency for research on cancer 'classification of carcinogenic substances': The case of asbestos
    Bernstein, David
    Gibbs, Allen
    Pooley, Fred
    Langer, Arthur
    Donaldson, Ken
    Hoskins, John
    Dunnigan, Jacques
    INDOOR AND BUILT ENVIRONMENT, 2007, 16 (02) : 94 - 98